Download fulltext HTML
Gilavand, F., Marzban, A., & Kavyanifard, A. (2019). L-Asparaginase-producing Rouxiella Species Isolation, Antileukemia Activity Evaluation, and Enzyme Production Optimization. Research in Molecular Medicine (RMM), 6(3). https://doi.org/10.18502/rmm.v6i3.4608

https://doi.org/10.18502/rmm.v6i3.4608

statistics

  • 283 Abstract Views
  • 302 PDF Views
  • 0 HTML Views
  • Cited by 1 article

authors

  • Farhad Gilavand

    Farhad Gilavand

    Department of Microbiology, Islamic Azad University, Khorramabad Branch, Khorramabad, Iran
  • Abdolrazagh Marzban

    Abdolrazagh Marzban

    Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences
  • Amirarsalan Kavyanifard

    Amirarsalan Kavyanifard

    Payame Noor University, Department of Biology, Tehran, Iran

Published Date

  • Jun 19, 2019

L-Asparaginase-producing Rouxiella Species Isolation, Antileukemia Activity Evaluation, and Enzyme Production Optimization

Research in Molecular Medicine (RMM) / Research in Molecular Medicine (RMM): Volume 6, Issue No. 3 /

Abstract

Background: L-Asparaginase (L-Asp) is used as an efficient anti-cancer drug, especially for acute lymphoblastic leukemia (ALL). Currently, two bacterial asparaginase isoenzymes are used for cancer treatment. Therefore, this research focused on isolating native bacteria with the ability to produce L-Asp.


Materials and Methods: L-Asp producing bacteria were isolated from soil samples on 9K medium supplemented with L-Asp as nitrogen source. Detection of L-Asp activity was performed by observing color change of the agar medium from yellow to orange due to the release of ammonia around the colonies. After the isolation and identification of the bacterium, L-Asp production was first optimized by the one factor-at-the-time (OFAT) technique followed by the response surface method. Next, the enzyme was extracted, purified, and assessed for antileukemia activity on U937 and MRC-5 cell lines.


Results: The results revealed that L-Asp produced by Rouxiella sp. AF1 significantly inhibited the growth of U937 cells at a dose of up to 0.04 IU/ml, while MRC-5 was not affected at any enzyme doses. The final purification of the enzyme was achieved by column chromatography (Sephadex G-100) at approximately 0.31 mg/ml, and its specific activity was determined to be 0.51 IU/mg. The OFAT optimization experiments were performed primarily to determine optimal enzyme conditions, which were found to be neutral pH (pH7), 30 ∘C temperature, and 3 % NaCl, 1 % peptone, and 1% glucose concentrations. Statistical optimization was based on five factors obtained from OFAT, and response surface method (RSM) analysis introduced a quadratic model for enzyme production at the optimal range of these variables. This model provided an equation for measuring the effect of physiochemical conditions on final enzyme production.


Conclusion: We showed that native bacteria may be novel candidates for isolating new metabolites such as L-Asp. Because many bacteria grow in unknown environments with unique ecological properties, the probability of discovering novel bacterial species producing bioactive compounds is high.

References
[1] Izadpanah QF, Homaei A, Fernandes P, Javadpour S. Marine microbial LAsparaginase: Biochemistry, molecular approaches and applications in tumor therapy and in food industry. Microbiol Res. 2018;208:99-112.

[2] Husain I, Sharma A, Kumar S, Malik F. Purification and characterization of glutaminase free asparaginase from Enterobacter cloacae: in-vitro evaluation of cytotoxic potential against human myeloid leukemia HL-60 cells. PloS One. 2016;11(2):e0148877.

[3] Egler RA, Ahuja SP, Matloub Y. L-Asparaginase in the treatment of patients with acute lymphoblastic leukemia. J Pharmacol Pharmacother. 2016;7(2):62.

[4] War Nongkhlaw FM, Joshi SR. L-Asparaginase and antioxidant activity of endophytic bacteria associated with ethnomedicinal plants. Indian Journal of Biotechnology. 2015;14(1):59-64.

[5] Ali U, Naveed M, Ullah A, Ali K, Shah SA, Fahad S, Mumtaz AS. L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): A novel approach to target alL. European Journal of Pharmacology. 2016; 771: 199-210.

[6] Ghorbanmovahed M, Ebrahimipour G, Akhtari J, Marzban A. Production of antileukemia L-Asparaginase by a strain of Staphylococcus Isolated from Agricultural Soil. Journal of Mazandaran University of Medical Sciences. 2016;25(132):1-12.

[7] Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST. Bergey’s Manual of Determinative Bacteriology. 9th ed. Baltimore: Williams & Wilkins; 1994.

[8] Teymouri M, Karkhane M, Marzban M, Marzban A. Designing a Response Surface Model for Removing Phosphate and Organic Compound from Wastewater by Pseudomonas Strain MT1. Proc Natl Acad Sci India Sect B Biol Sci. 2017;87(4):1167-76.

[9] Teymouri M, Karkhane M, Gilavand F, Akhtari J, Marzban A. Extracellular lipase purification from a marine Planomicrobium sp. MR23K and productivity optimization in a pilot-scale submerged bioreactor. Proc Natl Acad Sci India Sect B Biol Sci. 2018;88(2):739-46.

[10] Ramya LN, Doble M, Rekha VPB, Pulicherla KK. L-Asparaginase as potent antileukemic agent and its significance of having reduced glutaminase side activity for better treatment of acute lymphoblastic leukaemia. Appl Biochem Biotechnol. 2012;167(8):2144-59.

[11] El-Sabbagh SM, El-Batanony NH, Salem TA. L-Asparaginase produced by Streptomyces strain isolated from Egyptian soil: Purification, characterization and evaluation of its anti-tumor. Afr J Microbiol Res. 2013;7:5677-86.

[12] El-Bessoumy AA, Sarhan M, Mansour J. Production, isolation, and purification of LAsparaginase from Pseudomonas aeruginosa 50071 using solid-state fermentation. Journal of Biochemistry and Molecular Biology. 2004;37(4):387-93.

[13] Le Flèche-Matéos A, Kügler JH, Hansen SH, Syldatk C, Hausmann R, Lomprez F, et al. Rouxiella badensis sp. nov. and Rouxiella silvae sp. nov. isolated from peat bog soil and emendation description of the genus Rouxiella. Int J Syst Evol Microbiol. 2017;67(5):1255-9.

[14] Le Flèche-Matéos A, Levast M, Lomprez F, Arnoux Y, Andonian C, Perraud M, et al. Rouxiella chamberiensis gen. nov., sp. nov., a member of the family Enterobacteriaceae isolated from parenteral nutrition bags. Int J Syst Evol Microbiol. 2015;65(6):1812-8.

[15] Sharma A, Husain I. Optimization of medium components for extracellular glutaminase free asparaginase from Enterobacter cloacae. Int J Curr Microbiol App Sci. 2015;4(1):296-309.

[16] Chan WK, Lorenzi PL, Anishkin A, Purwaha P, Rogers DM, Sukharev S, et al. The glutaminase activity of L-Asparaginase is not required for anticancer activity against ASNS-negative cells. Blood. 2014:blood-2013-10-535112.

[17] Renuka DK, Santhi R, Sheeba D, Sangeetha R, Joshua S, Prabisha T, et al. Isolation, production and partial purification of L-Asparaginase from Serratia marcescens. Int J Recent Sci Res. 2012;3(1):1008-12.

[18] Han S, Jung J, Park W. Biochemical characterization of L-Asparaginase in NaCltolerant staphylococcus sp. OJ82 isolated from fermented seafood. J Microbiol Biotechnol. 2014;24(8):1096-104.

[19] Mukherjee J, Majumdar S, Scheper T. Studies on nutritional and oxygen requirements for production of L-Asparaginase by Enterobacter aerogenes. Appl Microbiol Biotechnol. 2000;53(2):180-4.

[20] Kenari SLD, Alemzadeh I, Maghsodi V. Production of L-Asparaginase from Escherichia coli ATCC 11303: Optimization by response surface methodology. Food and Bioproducts Processing. 2011;89(4):315-21.

[21] Moorthy V, Ramalingam A, Sumantha A, Shankaranaya RT. Production, purification and characterisation of extracellular L-Asparaginase from a soil isolate of Bacillus sp. African Journal of Microbiology Research. 2010;4(18):1862-7.

[22] El-Bessoumy AA, Sarhan M, Mansour J. Production, isolation, and purification of LAsparaginase from Pseudomonas aeruginosa 50071 using solid-state fermentation. BMB Reports. 2004;37(4):387-93.

[23] Singh Y, Gundampati RK, Jagannadham MV, Srivastava S. Extracellular LAsparaginase from a protease-deficient Bacillus aryabhattai ITBHU02: purification, biochemical characterization, and evaluation of antineoplastic activity in vitro. Appl Biochem Biotechnol. 2013;171(7):1759-74.

[24] Kumar S, Venkata Dasu V, Pakshirajan K. Purification and characterization of glutaminase-free L-Asparaginase from Pectobacterium carotovorum MTCC 1428. Bioresour Technol. 2011;102(2):2077-82.

[25] Manna S, Sinha A, Sadhukhan R, Chakrabarty S. Purification, characterization and antitumor activity of L-Asparaginase isolated from Pseudomonas stutzeri MB-405. Curr Microbiol. 1995;30(5):291-8.

[26] Pritsa AA, Kyriakidis DA. L-Asparaginase of Thermus thermophilus: Purification, properties and identificaation of essential amino acids for its catalytic activity. Mol Cell Biochem. 2001;216(1-2):93-101.

[27] Srikhanta YN, Atack JM, Beacham IR, Jennings MP. Distinct physiological roles for the two L-Asparaginase isozymes of Escherichia coli. Biochem Biophys Res Commun. 2013;436(3):362-5.

[28] Mahajan RV, Kumar V, Rajendran V, Saran S, Ghosh PC, Saxena RK. Purification and characterization of a novel and robust L-Asparaginase having low-glutaminase activity from Bacillus licheniformis: in vitro evaluation of anti-cancerous properties. PLoS One. 2014;9(6):e99037